A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

23K views

⸱

DOI:

10.3791/1916

⸱

April 23rd, 2010

 ,  ,  , 

In This Article

Summary

We describe a technique for the preparation of clarified human cortical homogenates, protein separation by SDS-PAGE, antigen retrieval and immunoblotting with an antibody to the Aβ peptide. Using this protocol, we consistently detect monomeric and multimeric Aβ in cortical tissue from humans with Alzheimer's pathology.

Abstract

The anomalous folding and polymerization of the β-amyloid (Aβ) peptide is thought to initiate the neurodegenerative cascade in Alzheimer's disease pathogenesis1. Aβ is predominantly a 40- or 42-amino acid peptide that is prone to self-aggregation into β-sheet-rich amyloid fibrils that are found in the cores of cerebral senile plaques in Alzheimer's disease. Increasing evidence suggests that low molecular weight, soluble Aβ multimers are more toxic than fibrillar Aβ amyloid2. The identification and quantification of low- and high-molecular weight multimeric Aβ species in brain tissue is an essential objective in Alzheimer's disease research, and the methods employed also can be applied to the identification and characterization of toxic multimers in other proteopathies3. Naturally occurring Aβ multimers can be detected by SDS-polyacrylamide gel electrophoresis followed by immunoblotting with Aβ-specific antibodies. However, the separation and detection of multimeric Aβ requires the use of highly concentrated cortical homogenates and antigen retrieval in small pore-size nitrocellulose membranes. Here we describe a technique for the preparation of clarified human cortical homogenates, separation of proteins by SDS-PAGE, and antigen-epitope retrieval/Western blotting with antibody 6E10 to the N-terminal region of the Aβ peptide. Using this protocol, we consistently detect Aβ monomers, dimers, trimers, tetramers, and higher molecular weight multimers in cortical tissue from humans with Alzheimer's pathology.

Protocol

Part 1: Preparation of clarified tissue homogenates

  1. Dounce homogenize unfixed cortical tissue in 4 times volume of ice-cold buffer (0.1M phosphate-buffered saline [Ca++- and Mg++-free] plus 2x protease inhibitor cocktail [Santa Cruz]) with approximately 30 even pestle strokes (i.e. add 400μl buffer to 100mg tissue).
  2. Spin homogenates for 5 minutes at 3,000g (4°C). Carefully remove clarified supernatants and store aliquots of these extracts at -80°C until use.
  3. Determine total protein concentration (μg/μl) for clarified homogenates using a bicinchoninic acid (BCA) assay, according to the manufacturer's instructions (ThermoFishe....

Access restricted. Please log in or start a trial to view this content.

Discussion

Despite the importance of Aβ aggregation in the pathogenesis of Alzheimer's disease1,4,5 , few studies have described or quantified the distribution of diverse Aβ multimers in human cortical tissue samples2. Commonly used immunohistochemical techniques do not allow for the discrimination of distinct multimeric Aβ species in fixed cortical tissue. In unfixed cortical tissue homogenates, Aβ multimers can be separated and biochemically assessed using gel electrophoresis and antibod.......

Access restricted. Please log in or start a trial to view this content.

Acknowledgements

Many thanks to Elaine Pranski and Carolyn Suwyn for excellent technical assistance and to Harry LeVine III, M. Paul Murphy, and Marla Gearing for important conversations. Funding was provided by RR-00165, PO1AG026423, P50AG025688, AG030539, the Woodruff Foundation and the Emory University Research Committee.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Complete Protease Inhibitor Cocktail TabletsSanta Cruz Biotechnology, Inc.Sc-291301 tablet in 25ml buffer
BCA Protein Assay kitThermo Fisher Scientific, Inc.23225
XCell SureLock Mini-Cell and XCell II Blot Module Kit CE MarkInvitrogenEI0002
Novex Tricine SDS Sample Buffer (2X)InvitrogenLC1676
NuPAGE Sample Reducing Agent (10X)InvitrogenNP0004
SeeBlue Plus2 Pre-Stained StandardInvitrogenLC5925
Novex 10-20% Tricine Gel 1.0 mm, 10 wellInvitrogenEC6625BOX
Nitrocellulose membranes, 0.2 μm pore sizeInvitrogenLC2000
Novex Tricine SDS Running Buffer (10X)InvitrogenLC1675
Novex Tris-Glycine Transfer Buffer (25X)InvitrogenLC3675
SimplyBlue SafeStainInvitrogenLC6060Will not interfere with immunostaining
ATX Ponceau S Red staining solutionSigma-Aldrich09276Will not interfere with immunostaining
Kapak heat sealable plastic sample pouchesFisher Scientific0181225AA
6E10 mouse monoclonal antibody to Aβ(1-16)CovanceSIG-39320Dilute 1:1,000 up to 1:5,000 for WB
Tween 20Sigma-AldrichP2287
ECL Mouse IgG, HRP-Linked Whole Aβ (from sheep)GE HealthcareNA931-1MLDilute at 1:10,000
SuperSignal West Pico Chemiluminescent SubstrateThermo Fisher Scientific, Inc.34077
Kodak Biomax MR FilmCarestream Health870 1302

References

  1. Hardy, J., Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297, 353-356 (2002).
  2. Haass, C., Selkoe, D. J. Soluble protein oligomers in n....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Abeta MultimersWestern BlottingProtein TransferHeat Induced Retrieval6E10 AntibodyBCA Assay